Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy.
Van Binnebeek S, Deroose CM, Baete K, Terwinghe C, Vanbilloen B, Koole M, Haustermans K, Mortelmans L, Verslype C, Van Cutsem E, Verbruggen A, Mottaghy FM. Van Binnebeek S, et al. Among authors: baete k. J Clin Oncol. 2011 Jul 1;29(19):e579-81. doi: 10.1200/JCO.2010.34.3384. Epub 2011 May 9. J Clin Oncol. 2011. PMID: 21555687 No abstract available.
Significant impact of transient deterioration of renal function on dosimetry in PRRT.
Van Binnebeek S, Baete K, Terwinghe C, Vanbilloen B, Haustermans K, Mortelmans L, Borbath I, Van Cutsem E, Verslype C, Mottaghy FM, Verbruggen A, Deroose CM. Van Binnebeek S, et al. Among authors: baete k. Ann Nucl Med. 2013 Jan;27(1):74-7. doi: 10.1007/s12149-012-0651-y. Epub 2012 Sep 9. Ann Nucl Med. 2013. PMID: 22961123
Individualized dosimetry-based activity reduction of ⁹⁰Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy.
Van Binnebeek S, Baete K, Vanbilloen B, Terwinghe C, Koole M, Mottaghy FM, Clement PM, Mortelmans L, Haustermans K, Van Cutsem E, Verbruggen A, Bogaerts K, Verslype C, Deroose CM. Van Binnebeek S, et al. Among authors: baete k. Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1141-57. doi: 10.1007/s00259-013-2670-x. Epub 2014 Mar 26. Eur J Nucl Med Mol Imaging. 2014. PMID: 24668274 Clinical Trial.
Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours.
Van Binnebeek S, Vanbilloen B, Baete K, Terwinghe C, Koole M, Mottaghy FM, Clement PM, Mortelmans L, Bogaerts K, Haustermans K, Nackaerts K, Van Cutsem E, Verslype C, Verbruggen A, Deroose CM. Van Binnebeek S, et al. Among authors: baete k. Eur Radiol. 2016 Mar;26(3):900-9. doi: 10.1007/s00330-015-3882-1. Epub 2015 Jul 12. Eur Radiol. 2016. PMID: 26162577 Clinical Trial.
36 results